AI Tool Comparison
Comparing as AI Remote Patient MonitoringCadence vs Current Health
Compare features, pricing, pros & cons, and user ratings to decide which AI tool is best for your needs.
Cadence
VS
Current Health
Verdict by Category
Detailed category analysis is not available for this comparison.
Detailed Comparison
Feature
Cadence
Current Health
Pricing
EnterpriseCadence is an enterprise-only platform with no public pricing. All deployments are custom contracts negotiated directly with health systems and payers.
Many Cadence programs are Medicare-reimbursable: Remote Patient Monitoring (RPM) codes and Advanced Primary Care Management (APCM) codes for qualifying Medicare patients provide a reimbursement pathway that reduces net cost for health systems. Published ROI data shows a 3:1 return to Medicare for every dollar spent.
Contact Cadence through cadence.care for health system partnership and pricing discussions.
EnterpriseCurrent Health is an enterprise-only platform with no public pricing. All deployments are custom contracts negotiated directly with health systems, payers, and home health agencies.
Pricing is based on patient volume, care program type (Hospital@Home, chronic care management, post-acute monitoring), integration requirements, and the level of Clinical Command Center support required.
Contact Current Health through currenthealth.com to request a demo and enterprise pricing discussion.
Categories
AI Healthcare ToolsAI Research & Education Tools
AI Healthcare ToolsAI Productivity Tools
Summary
Clinical AI with supervised agents for chronic disease care — 27% fewer admissions, 3:1 Medicare ROI
Enterprise care-at-home platform — FDA-cleared wearable monitoring, telehealth, and clinical command center
Cadence Pros & Cons
Pros
- Supervised AI agents automate high-volume chronic care tasks under physician oversight — unique clinical AI approach
- $100M Series C (June 2026) at $1.23B valuation — Spark Capital-backed with strong financial momentum
- 27% reduction in hospital admissions, $1,302 lower annual care cost per patient — peer-reviewed outcomes
- 3:1 Medicare ROI published — stronger economic validation than most RPM competitors
- Medicare RPM and APCM reimbursement support — reduces net cost burden on health systems
- Outcomes consistent across rural and underserved communities — proven equity in care access
- Hybrid AI + human clinical team model — AI amplifies clinicians rather than replacing them
Cons
- Enterprise health system sales cycle is long — not accessible to individual practices or small clinics
- No public pricing — all contracts custom negotiated with health systems
- Currently focused on seniors/Medicare population — less suited for younger patient populations
- 90,000+ patient scale is growing but still smaller than Teladoc or Biofourmis
- Dependent on Medicare reimbursement rates — policy changes could impact economics
- AI agents require ongoing physician supervision — not fully autonomous
Current Health Pros & Cons
Pros
- FDA-cleared wearable delivers ICU-level vital sign accuracy at home — highest clinical standard in consumer RPM
- Acquired by Best Buy (2021) — enterprise-scale logistics, retail distribution, and commercial backing
- Trusted by Mount Sinai, Geisinger, Mayo Clinic, UK NHS, and AstraZeneca — proven at top-tier health systems
- All-in-one platform: RPM + telehealth + patient engagement + command center in single solution
- 24/7 Clinical Command Center reduces provider burden — offloads monitoring operations from health system staff
- Customizable clinical algorithms per patient — reduces false alarms and focuses alerts on clinically meaningful signals
- Revenues grew 3,000% YoY in 2020 — proven market demand and real-world scalability
Cons
- Enterprise-only platform — not available for individual clinicians or small practices
- Requires Best Buy Health partnership for full deployment — limits flexibility for some health systems
- No public pricing — evaluation requires direct sales engagement
- Device-dependent model — requires wearable distribution logistics and patient onboarding
- Primarily focused on US and UK markets
- Competition from Biofourmis, Teladoc, and other RPM platforms with similar hospital-at-home capabilities